Mitogen Activated Protein Kinase (MAPK) Activation, p53, and Autophagy Inhibition Characterize the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein Induced Neurotoxicity-Reference-Cited by-同舟云学术

Mitogen Activated Protein Kinase (MAPK) Activation, p53, and Autophagy Inhibition Characterize the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein Induced Neurotoxicity

Published:2022-12-09 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Kyriakopoulos Anthony M,Nigh Greg,McCullough Peter A,Seneff Stephanie

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference143 articles.

1. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact;Davis HE;EClinicalMedicine,2021

2. Inflammatory response leads to neuronal death in human post-mortem cerebral cortex in patients with COVID-19;Boroujeni ME;ACS Chem Neurosci,2021

3. SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: evidence of PAMP-like properties;Frank MG;Brain Behav Immun,2022

4. SARS-CoV-2 spike protein interactions with amyloidogenic proteins: potential clues to neurodegeneration;Idrees D;Biochem Biophys Res Commun,2021

5. Amyloidogenesis of SARS-CoV-2 spike protein;Nyström S;J Am Chem Soc,2022

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical rationale for dietary lutein supplementation in long COVID and mRNA vaccine injury syndromes;F1000Research;2024-08-06

2. Promising Strategies to Reduce the SARS-CoV-2 Amyloid Deposition in the Brain and Prevent COVID-19-Exacerbated Dementia and Alzheimer’s Disease;Pharmaceuticals;2024-06-16

3. Melatonin: a ferroptosis inhibitor with potential therapeutic efficacy for the post-COVID-19 trajectory of accelerated brain aging and neurodegeneration;Molecular Neurodegeneration;2024-04-19

4. Accelerated tumor progression after COVID-19 infection in patients with glioblastoma: A retrospective case–control study;Neuro-Oncology Practice;2024-04-08

5. Impacts of the SARS-CoV-2 Spike Protein on the Innate Immune System: A Review;Cureus;2024-03-26